Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>RadNet, Inc. reported its second quarter 2026 financial results marked by strong growth and record performance across both its Imaging Center and Digital Health segments.</li><li>The company’s total revenue increased by 25% year-over-year to $622.7 million, while adjusted EBITDA rose by 22.7% to $99.7 million.</li><li>This broad-based growth was supported by higher procedural volumes, including a notable shift toward advanced imaging modalities such as MRI, CT, and PET/CT, which contributed to an increase in the advanced imaging mix from 27.5% to 29.9% of total procedural volume.</li></ul>

RadNet, Inc. reported its second quarter 2026 financial results marked by strong growth and record performance across both its Imaging Center and Digital Health segments.The company’s total revenue increased by 25% year-over-year to $622.7 million, while adjusted EBITDA rose by 22.7% to $99.7 million.This broad-based growth was supported by higher procedural volumes, including a notable shift toward advanced imaging modalities such as MRI, CT, and PET/CT, which contributed to an increase in the advanced imaging mix from 27.5% to 29.9% of total procedural volume.

RadNet’s $622.7 Million Quarter: Is AI Becoming The Hidden Catalyst?

Radnet Inc

RadNet’s $622.7 Million Quarter: Is AI Becoming The Hidden Catalyst?